Navigation Links
avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
Date:7/16/2009

LUMBY, BC, July 16 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products announced that the Company has hired a web design firm to design avVaa World Health Care's product web site for the Neuroskin(R) campaign. The new site will include an up-to-date look and feel, customer friendly navigation, and areas where customers and prospective customers can ask questions and interact.

Lorie Campbell-Farley, President/COO of avvaa commented by saying, "our sales and marketing division at avVaa World Health Care will aggressively undertake both direct response TV marketing and internet marketing initiatives to drive sales in targeted market areas."

Avvaa recognizes that having an online presence is paramount these days, and as such, the Company is taking the steps to build a dynamic website that is easy to navigate, informative and communicates the Company's message the best way possible.

The core products for the company's official site, which will be named at a later date include NEUROSKIN(R) Psoriasis Relief, NEUROSKIN(R)Acne Treatment, NEUROSKIN(R) Itch Relief and NEUROSKIN(R) mild Skin Moisturizer followed by future avVaa Care Skin Treatments and avVaa Care Medi Spa products.

    About avVaa World Health Care Products
    --------------------------------------

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.


'/>"/>
SOURCE avVaa World Health Care Products
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
2. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
3. New Scientific Worldview Biocentrism Featured in The Huffington Post - #1 Weblog in the World
4. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
5. Material world: Graphenes versatility promises new applications
6. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
7. New Report Just Published: World Prostate Cancer Therapeutics Market Report
8. New Report Just Published: World Endoscopy Systems Market Report
9. Celebrities to Gather to Support the Ninth Annual Starkey Hearing Foundation So the World May Hear Awards Gala
10. Essilor: Essilor Forges New Strategic Partnerships Around the World
11. Bio/Data Corporation Launches vW Select(TM) - The Worlds First and Only Complete Ristocetin CoFactor Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):